These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 4577936

  • 1. Dantrolene sodium: long-term effects in severe spasticity.
    Chyatte SB, Basmajian JV.
    Arch Phys Med Rehabil; 1973 Jul; 54(7):311-5. PubMed ID: 4577936
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Spasticity and the effect of dantrolene sodium.
    Monster AW.
    Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam.
    Schmidt RT, Lee RH, Spehlmann R.
    Trans Am Neurol Assoc; 1975 Aug; 100():235-7. PubMed ID: 1226625
    [No Abstract] [Full Text] [Related]

  • 5. Dantrolene sodium in children with spasticity.
    Haslam RH, Walcher JR, Lietman PS, Kallman CH, Mellits ED.
    Arch Phys Med Rehabil; 1974 Aug; 55(8):384-8. PubMed ID: 4604292
    [No Abstract] [Full Text] [Related]

  • 6. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity].
    Ladd HW, Gingras G, Boucher J, Kazdan N, Keenan R.
    Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dantrolene sodium: long-term effects in patients with muscle spasticity.
    Joynt RL.
    Arch Phys Med Rehabil; 1976 May; 57(5):212-7. PubMed ID: 776122
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical assessment and pharmacologic therapy of spasticity.
    Pedersen E.
    Arch Phys Med Rehabil; 1974 Aug; 55(8):344-54. PubMed ID: 4277407
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dantrolene sodium for treatment of spasticity.
    Med Lett Drugs Ther; 1974 Jul 19; 16(15):61-2. PubMed ID: 4843632
    [No Abstract] [Full Text] [Related]

  • 15. Dantrolene: new indication. Cerebral palsy in children: uncertain clinical benefit.
    Prescrire Int; 2008 Dec 19; 17(98):237. PubMed ID: 19422149
    [Abstract] [Full Text] [Related]

  • 16. Treatment of spastic cerebral-palsied children with sodium dantrolene.
    Denhoff E, Feldman S, Smith MG, Litchman H, Holden W.
    Dev Med Child Neurol; 1975 Dec 19; 17(6):736-42. PubMed ID: 1107103
    [No Abstract] [Full Text] [Related]

  • 17. The effect of dantrolene sodium on spasticity in multiple sclerosis.
    Gelenberg AJ, Poskanzer DC.
    Neurology; 1973 Dec 19; 23(12):1313-5. PubMed ID: 4796610
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Schmidt RT, Lee RH, Spehlmann R.
    J Neurol Neurosurg Psychiatry; 1976 Apr 19; 39(4):350-6. PubMed ID: 778344
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
    Tolosa ES, Soll RW, Loewenson RB.
    JAMA; 1975 Sep 08; 233(10):1046. PubMed ID: 1099254
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.